Antibiotic policies and the role of strategic hospital leadership

被引:6
作者
Masterton, RG [1 ]
机构
[1] Western Gen Hosp NHS Trust, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
antibiotic policies; hospital leadership;
D O I
10.1016/S0195-6701(99)90096-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Operational aspects, programme construction and implementation are all essential components of antimicrobial control but are not the direct remit of management and must rest with the professional provider. Hospital leaders call influence antibiotic control through the priority they give it. This must not be purely financially driven and must incorporate an awareness of issues surrounding patient care. Such attitudes should encompass the consequences of poor prescribing practices in both human and corporate terms. A leader's recognition of these elements can be expressed through securing resources ill terms of both the human and hardware components. The best signalling of the status of this activity is through ensuring its inclusion in clinical governance and organisational Board reports. The goals for hospital leaders should be evidence of effective working practices and the execution of their own responsibilities by championing robust structures and procedures are in place. Potent hospital leadership delivered to the focus of antimicrobial control programmes is a major tool for their success. (C) 1999 The Hospital Infection Society.
引用
收藏
页码:S261 / S264
页数:4
相关论文
共 8 条
[1]  
AVORN J, 1987, REV INFECT DIS, V9, pS286
[2]  
CHANTLER C, 1998, CLIN MANAGEMENT, V7, P15
[3]   Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership [J].
Goldmann, DA ;
Weinstein, RA ;
Wenzel, RP ;
Tablan, OC ;
Duma, RJ ;
Gaynes, RP ;
Schlosser, J ;
Martone, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :234-240
[4]  
GOULD IM, 1994, J ANTIMICROB CHEMOTH, V34, P21
[5]  
MASTERTON RG, 1998, CLIN PRACT S, V95, P9
[6]   The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally [J].
OBrien, TF .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S2-S8
[7]  
Standing Medical Advisory Committee subgroup on antimicrobial resistance, 1998, PATH LEAST RES
[8]  
WILCOCK PM, 1998, HEALTHCARE QUALITY, V4, P21